Insulin therapy

Insulin therapy is recommended for patients with type 2 diabetes mellitus and an initial A1C level greater than 9 percent, or if diabetes is uncontrolled despite optimal oral glycemic therapy. Insulin therapy may be initiated as augmentation, starting at 0.3 unit per kg, or as replacement, starting at 0.6 to 1.0 unit per kg. When using replacement therapy, 50 percent of the total daily insulin dose is given as basal, and 50 percent as bolus, divided up before breakfast, lunch, and dinner. Augmentation therapy can include basal or bolus insulin. Replacement therapy includes basal-bolus insulin and correction or premixed insulin.

    Related Conference of Insulin therapy

    June 20-21, 2018

    27th European Diabetes Congress

    | Rome, Italy
    July 16-17, 2018 Sydney, Australia

    20th Asia Pacific Diabetes Conference

    July 23-24, 2018

    Global Meeting on Diabetes and Endocrinology

    Kuala Lumpur, Malaysia
    August 20-21, 2018

    28th World Congress on Diabetes, Obesity & Heart

    Tokyo, Japan
    September 03-04, 2018

    2nd International Conference on Thyroid and Pregnancy

    Auckland, New Zealand
    September 3-4, 2018

    11th World Congress on Endocrinology and Metabolic Disorders

    Auckland, New Zealand
    September 13-15, 2018

    26th International Diabetes and Healthcare Conference

    Bucharest, Romania
    Sep 14-15, 2018

    World Congress on Endocrinology

    Prague , Czech Republic
    Sep 14-15, 2018

    Euro Diabetes Congress & Expo

    | Prague, Czech Republic
    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland

    Insulin therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in